Drug Type Small molecule drug |
Synonyms ZH-26 |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), PDGF inhibitors(PDGF ligand inhibitors), SRC inhibitors(Tyrosine-protein kinase SRC inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Discovery | CN | - |